Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2025 ,inter alia, to consider and approve the Audited (Standalone & ....
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal PathLabs has informed the stock exchanges that its Board of Directors will meet on Friday, April 25, 2025. The main agenda is to consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2025. The Board will also consider recommending a Final Dividend, if any, on equity shares for FY25. The trading window for dealing in company securities is already closed and will reopen 48 hours after the financial results are declared.
This is a routine pre-results announcement — no actual numbers are disclosed yet. Investors should watch for the Q4/FY25 results and any final dividend declaration on April 25, which could influence the stock price and near-term sentiment.